Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 100 of 120 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/23
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 12/14/21
End: 07/30/33
Due: 07/30/34
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 09/05/22
Due: 09/05/23
Phase: N/A
Priority: Normal
Start: 04/14/23
End: 04/13/25
Due: 04/13/26
Phase: N/A
Priority: Normal
Start: 07/24/24
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 04/23/18
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 02/17/22
End: 09/08/22
Due: 09/08/23
Phase: N/A
Priority: Normal
Start: 10/14/20
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 07/02/20
End: 04/02/21
Due: 04/02/22
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 08/30/23
End: 04/30/24
Due: 04/30/25
Phase: N/A
Priority: Normal
Start: 04/25/23
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 11/07/21
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 10/11/16
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 08/01/21
End: 10/31/22
Due: 10/31/23
Phase: N/A
Priority: Normal
Start: 08/22/22
End: 02/01/32
Due: 02/01/33
Phase: N/A
Priority: Normal
Start: 06/29/20
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 07/22/20
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 07/22/19
End: 01/22/20
Due: 01/22/21
Phase: N/A
Priority: Normal
Start: 06/13/19
End: 01/01/23
Due: 01/01/24
Phase: N/A
Priority: Normal
Start: 02/28/25
End: 12/31/26
Due: 12/31/27
Effect of Repeated Low-Level Red-Light Therapy on Visual Field Damage in Primary Open-angle Glaucoma
Phase: N/A
Priority: Normal
Start: 04/01/22
End: 09/30/23
Due: 09/30/24
Phase: N/A
Priority: Normal
Start: 05/31/25
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 12/05/22
End: 11/30/27
Due: 11/30/28
Phase: N/A
Priority: Normal
Start: 10/15/22
End: 05/31/23
Due: 05/31/24